Aesthetics Clinical Guide
Exosome Therapy for Skin and Hair: Hype vs. Data
What they are
What Exosomes Actually Are
Exosomes are small (~30–150 nm) extracellular vesicles released by virtually all cell types. They carry proteins, lipid signals, mRNA, and microRNA cargo and play a documented role in cell-to-cell signaling, immune modulation, and tissue regeneration.
In aesthetic medicine, exosome preparations are most often derived from cultured mesenchymal stem cells (MSCs) — typically umbilical-cord-derived — or from platelets, adipose tissue, or plant sources. They are applied topically (especially post-laser or microneedling) or injected into the scalp for hair restoration.
FDA position
FDA Warning: Read This Before Paying
FDA says "there are currently no FDA-approved exosome products" (Public Safety Notification on Exosome Products, December 6, 2019; repeated in a July 22, 2020 consumer alert). The 2019 notification reported serious adverse events in patients in Nebraska who were treated with unapproved products marketed as containing exosomes, and said exosomes used to treat diseases and conditions in humans are regulated as drugs and biological products. FDA has since sent warning letters to companies selling exosome products, including in 2025 and 2026. For the full regulatory answer, see Are Exosomes FDA-Approved for Aesthetic Use?.
FDA's pages don't create a separate category for aesthetic use. Its cosmetics guidance says a product's intended use, shown by its claims, decides whether it is a cosmetic or a drug, and it lists claims to "restore hair growth" or "regenerate cells" as drug claims. FDA also says it has not cleared any microneedling device for use with another product. FDA suggests asking whether FDA has reviewed the treatment, and for the IND number if you're told it is part of a study. Patients should explicitly ask: what is the source of the exosomes, how was the preparation tested for sterility and identity, and is there documentation of the supplier's quality program?
A reputable physician will have answers and source documentation. The lack of either is a red flag.
Evidence
What the Clinical Evidence Actually Shows
For hair restoration: small open-label and split-scalp series report measurable increases in hair count and density when exosomes are added to microneedling, particularly in early androgenetic alopecia. Comparable studies of PRP show similar or better effect sizes with longer-term data; head-to-head trials remain limited.
For skin rejuvenation: exosomes applied topically after fractional laser are widely used in practice; published data suggest faster erythema resolution and improved patient-reported recovery. Independent placebo-controlled human evidence remains modest.
Bottom line: the mechanism is biologically interesting, early outcomes are suggestive, controlled human data are limited, and product quality is the dominant variable. This is not a category to choose by price.
Where they fit
Where Exosomes Sensibly Fit (and Don't)
- ·As a topical adjunct immediately post-fractional or ablative laser, applied to occluded skin during the early healing window.
- ·As an adjunct to microneedling for early androgenetic alopecia in patients who are not candidates for or who decline finasteride/minoxidil.
- ·They are not a substitute for finasteride, minoxidil, or surgical hair restoration in patients with advanced loss.
- ·They are not a substitute for laser, retinoids, or filler in skin rejuvenation.
- ·Injected exosomes for general anti-aging or wellness indications are not supported by data and carry regulatory and safety concerns.
Choosing a provider
How to Vet an Exosome Provider
- ·Ask for the supplier name and quality documentation.
- ·Ask whether the product is being used topically or injected, and what it is claimed to do.
- ·Ask the provider to articulate the data — not just the marketing.
- ·Be skeptical of clinics offering IV or systemic exosome infusions for wellness or longevity indications. FDA says no exosome product is approved, for any use.
- ·Board-certified dermatologists and plastic surgeons with explicit experience in regenerative aesthetics are the appropriate operators.
Frequently asked
Common questions
Is exosome therapy FDA-approved?
No. FDA says there are currently no FDA-approved exosome products (Public Safety Notification, December 6, 2019; Consumer Alert, July 22, 2020). FDA's pages don't create an exception for cosmetic or post-procedure use: a product's intended use, shown by its claims, decides how FDA treats it. See Are Exosomes FDA-Approved for Aesthetic Use? for details.
Do exosomes work for hair loss?
Early data — mostly small open-label series — suggest benefit as an adjunct to microneedling in early androgenetic alopecia. They are not a replacement for finasteride, minoxidil, or hair transplant in advanced cases.
Are exosomes the same as PRP?
No. PRP uses your own platelet-rich plasma drawn at the visit. Exosomes are typically derived from cultured stem cells from an outside source. The mechanism overlaps; the regulatory and sourcing considerations are very different.
Are IV exosome infusions safe?
FDA says no exosome product is approved, and its 2019 notification reported serious adverse events in patients in Nebraska treated with unapproved exosome products. FDA does not publish safety rates for exosomes. This is not a service to choose by price.
What should I ask a provider?
Ask for the supplier name, quality documentation, route of administration, and what the provider has personally seen in their own practice — not the marketing claims.
References
Sources
- 1.Public Safety Notification on Exosome Products — U.S. Food and Drug Administration, December 6, 2019.
- 2.Exosomes in dermatology: a review of the current literature — Journal of the American Academy of Dermatology, 2023.
- 3.Exosome therapy in androgenetic alopecia — early clinical experience — Dermatologic Surgery, 2023.
- 4.Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes — U.S. Food and Drug Administration, July 22, 2020.
- 5.Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?) — U.S. Food and Drug Administration.
Related